The amount of shares on the buy side is close to shares on issue. 834m shares on issue, 810m on the buy side including Chi-X. Although I guess we can forget about those buying at 0.1c.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025